IDEXX Laboratories Aktie

IDEXX Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 888210 / ISIN: US45168D1046

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
31.10.2017 12:17:43

IDEXX Laboratories Inc Reveals 25% Advance In Q3 Bottom Line

(RTTNews) - IDEXX Laboratories Inc (IDXX) revealed earnings for its third quarter that gained ground from last year.

The company said its bottom line climbed to $70.51 million, or $0.79 per share. This was higher than $56.46 million, or $0.62 per share, in last year's third quarter.

Analysts had expected the company to earn $0.74 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 9.7% to $491.98 million. This was up from $448.31 million last year.

IDEXX Laboratories Inc earnings at a glance:

-Earnings (Q3): $70.51 Mln. vs. $56.46 Mln. last year. -Earnings Growth (Y-o-Y): 24.9% -EPS (Q3): $0.79 vs. $0.62 last year. -EPS Growth (Y-o-Y): 27.4% -Analysts Estimate: $0.74 -Revenue (Q3): $491.98 Mln vs. $448.31 Mln last year. -Revenue Change (Y-o-Y): 9.7%

-Guidance: Full year EPS guidance: $3.22 - $3.26 Full year revenue guidance: $1.95 - $ 1.96 Bln

Analysen zu IDEXX Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

IDEXX Laboratories 344,60 -4,36% IDEXX Laboratories